Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Sunder Biomedical Tech. Co., Ltd. (4115) Financial Statements

Sunder Biomedical Tech. Co., Ltd. Financial Overview

Sunder Biomedical Tech. Co., Ltd.'s market cap is currently NT$418.20M. The company's EPS TTM is NT$0.10; its P/E ratio is 71.41; and it has a dividend yield of 1.74%. Sunder Biomedical Tech. Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 753.45MNT$ 766.83MNT$ 770.19MNT$ 1.05BNT$ 1.14B
Gross ProfitNT$ 102.48MNT$ 142.11MNT$ 77.91MNT$ 140.52MNT$ 200.78M
Operating IncomeNT$ -18.33MNT$ 24.09MNT$ -37.41MNT$ 15.80MNT$ 80.91M
EBITDANT$ 68.43MNT$ 125.61MNT$ 76.61MNT$ 127.49MNT$ 193.39M
Net IncomeNT$ -16.26MNT$ 29.10MNT$ -33.16MNT$ 13.32MNT$ 71.06M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 122.39MNT$ 145.58MNT$ 163.82MNT$ 160.13MNT$ 207.78M
Total AssetsNT$ 1.27BNT$ 1.32BNT$ 1.41BNT$ 1.43BNT$ 1.53B
Total DebtNT$ 388.67MNT$ 401.46MNT$ 491.29MNT$ 476.55MNT$ 526.89M
Net DebtNT$ 289.44MNT$ 271.03MNT$ 394.60MNT$ 342.92MNT$ 399.25M
Total LiabilitiesNT$ 515.74MNT$ 540.04MNT$ 669.40MNT$ 635.02MNT$ 723.08M
Stockholders' EquityNT$ 757.92MNT$ 777.43MNT$ 735.89MNT$ 790.45MNT$ 809.01M
Cash Flow
Free Cash FlowNT$ -7.85MNT$ 9.98MNT$ -13.83MNT$ 30.58MNT$ 83.13M
Operating Cash FlowNT$ 70.59MNT$ 108.13MNT$ 47.41MNT$ 104.42MNT$ 177.86M
Investing Cash FlowNT$ -90.15MNT$ 9.25MNT$ -101.21MNT$ -4.60MNT$ -70.98M
Financing Cash FlowNT$ -10.44MNT$ -97.41MNT$ 30.52MNT$ -94.65MNT$ -94.60M

Currency in TWD

Sunder Biomedical Tech. Co., Ltd. Earnings and Revenue History

-600M0600M1.2B-5 %0 %5 %10 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Sunder Biomedical Tech. Co., Ltd. Liabilities to Assets

0600M1.2B1.8B40 %44 %48 %52 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Sunder Biomedical Tech. Co., Ltd. Cash Flow

-200M-100M0100M200M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Sunder Biomedical Tech. Co., Ltd. Forecast EPS vs Actual EPS

Earnings >